CN115041138A - Phosphorylated peptide adsorbent using nano diamond as substrate and preparation and application thereof - Google Patents
Phosphorylated peptide adsorbent using nano diamond as substrate and preparation and application thereof Download PDFInfo
- Publication number
- CN115041138A CN115041138A CN202110249329.1A CN202110249329A CN115041138A CN 115041138 A CN115041138 A CN 115041138A CN 202110249329 A CN202110249329 A CN 202110249329A CN 115041138 A CN115041138 A CN 115041138A
- Authority
- CN
- China
- Prior art keywords
- imac
- diamond
- adsorbent
- nano
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003463 adsorbent Substances 0.000 title claims abstract description 28
- 239000002113 nanodiamond Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 12
- 239000000758 substrate Substances 0.000 title claims 4
- 239000000463 material Substances 0.000 claims abstract description 70
- RGZHEOWNTDJLAQ-UHFFFAOYSA-N 3,4,5-trihydroxybenzaldehyde Chemical compound OC1=CC(C=O)=CC(O)=C1O RGZHEOWNTDJLAQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 12
- 239000002245 particle Substances 0.000 claims abstract description 11
- 239000003446 ligand Substances 0.000 claims abstract description 10
- 238000001042 affinity chromatography Methods 0.000 claims abstract description 6
- 238000006482 condensation reaction Methods 0.000 claims abstract description 5
- 239000012472 biological sample Substances 0.000 claims abstract description 4
- 239000010432 diamond Substances 0.000 claims abstract description 4
- 229910003460 diamond Inorganic materials 0.000 claims abstract description 4
- 239000003607 modifier Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229910052726 zirconium Inorganic materials 0.000 claims description 8
- -1 zirconium ions Chemical class 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000008204 material by function Substances 0.000 claims description 5
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 claims description 5
- 239000002262 Schiff base Substances 0.000 claims description 4
- 150000004753 Schiff bases Chemical class 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims 5
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims 5
- MQOFFKNNIBZAQJ-UHFFFAOYSA-N C1(=CC=CC=C1)O.C1(=CC=CC=C1)O.C1(=CC=CC=C1)O.C1(=CC=CC=C1)C1=CC=CC=C1 Chemical group C1(=CC=CC=C1)O.C1(=CC=CC=C1)O.C1(=CC=CC=C1)O.C1(=CC=CC=C1)C1=CC=CC=C1 MQOFFKNNIBZAQJ-UHFFFAOYSA-N 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 108010001441 Phosphopeptides Proteins 0.000 abstract description 57
- 230000009920 chelation Effects 0.000 abstract description 7
- 239000003480 eluent Substances 0.000 abstract description 6
- 239000011159 matrix material Substances 0.000 abstract description 6
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallyl group Chemical group C1(=C(C(=CC=C1)O)O)O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003929 acidic solution Substances 0.000 abstract description 5
- 239000002594 sorbent Substances 0.000 abstract description 5
- 238000001179 sorption measurement Methods 0.000 abstract description 5
- 125000003277 amino group Chemical group 0.000 abstract description 4
- 238000011067 equilibration Methods 0.000 abstract description 2
- GBNDTYKAOXLLID-UHFFFAOYSA-N zirconium(4+) ion Chemical compound [Zr+4] GBNDTYKAOXLLID-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000717 retained effect Effects 0.000 abstract 1
- 102000011632 Caseins Human genes 0.000 description 12
- 108010076119 Caseins Proteins 0.000 description 12
- 238000001597 immobilized metal affinity chromatography Methods 0.000 description 12
- 235000021247 β-casein Nutrition 0.000 description 12
- 239000012634 fragment Substances 0.000 description 8
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- 238000003760 magnetic stirring Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000002186 photoelectron spectrum Methods 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical group NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000012863 analytical testing Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000010201 enrichment analysis Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- DCKVFVYPWDKYDN-UHFFFAOYSA-L oxygen(2-);titanium(4+);sulfate Chemical compound [O-2].[Ti+4].[O-]S([O-])(=O)=O DCKVFVYPWDKYDN-UHFFFAOYSA-L 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910000348 titanium sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/48—Sorbents characterised by the starting material used for their preparation
- B01J2220/4806—Sorbents characterised by the starting material used for their preparation the starting material being of inorganic character
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/48—Sorbents characterised by the starting material used for their preparation
- B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Carbon And Carbon Compounds (AREA)
Abstract
本发明涉及一种可重复使用的以纳米金刚石为基质的磷酸化肽吸附材料及其制备和应用。具体是以表面带有氨基的纳米金刚石为基质,3,4,5‑三羟基苯甲醛为修饰剂,采用氨醛缩合反应在金刚石微粒表面引入联苯三酚基团,该基团作为配体可以与锆离子(Zr4+)进行螯合,所得到的材料可以用作固定化金属离子亲和色谱(Immobilized metal affinity chromatography,IMAC)的吸附剂,用来富集复杂生物样品中的磷酸肽。由于Zr4+与联苯三酚之间的螯合作用力大于其与磷酸基团之间的螯合作用力,在富集完成之后,通过使用恰当的碱性洗脱剂,可使磷酸肽从吸附剂上洗脱的同时保留吸附剂上螯合的Zr4+,因此,用酸性溶液重新平衡后,吸附剂可再次进行使用。
The present invention relates to a reusable phosphorylated peptide adsorption material with nano-diamond as matrix and its preparation and application. Specifically, a nano-diamond with amino groups on the surface is used as the matrix, 3,4,5-trihydroxybenzaldehyde is used as a modifier, and an amino-aldehyde condensation reaction is used to introduce a pyrogallol group on the surface of the diamond particles, and the group is used as a ligand. It can be chelated with zirconium ion (Zr 4+ ), and the obtained material can be used as an adsorbent for immobilized metal ion affinity chromatography (IMAC) to enrich phosphopeptides in complex biological samples . Since the chelation force between Zr 4+ and biphloroglucinol is greater than that between it and the phosphate group, after the enrichment is completed, by using an appropriate alkaline eluent, the phosphopeptide can be removed from the adsorption. The chelated Zr 4+ on the sorbent is retained while eluting on the sorbent, so the sorbent can be used again after re-equilibration with an acidic solution.
Description
技术领域technical field
本发明涉及一种可重复使用的Zr4+-IMAC吸附材料,具体是以表面带有氨基的纳米金刚石为基质,依次用3,4,5-三羟基苯甲醛和Zr4+进行修饰,制备一种可重复使用的固定化金属离子亲和色谱(Immobilized metal affinity chromatography,IMAC)吸附剂,用于分离富集复杂样品中的磷酸化肽段。The invention relates to a reusable Zr 4+ -IMAC adsorption material. Specifically, a nano-diamond with amino groups on the surface is used as a matrix, and 3, 4, 5-trihydroxybenzaldehyde and Zr 4+ are sequentially modified to prepare A reusable immobilized metal affinity chromatography (IMAC) adsorbent for separation and enrichment of phosphorylated peptides in complex samples.
背景技术Background technique
作为一种非常重要的蛋白质翻译后修饰,磷酸化修饰参与了几乎所有的生命活动,如细胞的增殖、分化、凋亡以及神经活动等。磷酸化的异常通常会导致某些疾病的发生,如恶性肿瘤,老年痴呆等。因此,研究蛋白质的磷酸化修饰的过程和机理对于疾病的预防、控制和治疗具有重要意义(文献1,Humphrey S.J.,et.al"High-throughputphosphoproteomics reveals in vivo insulin signaling dynamics"Nat.Biotechnol.2015,33,990-995;文献2,Jiang,Y.,et al."Proteomics identifiesnew therapeutic targets of early-stage hepatocellular carcinoma".Nature 2019,567,258–261)。基于“鸟枪法”的蛋白质组学分析策略是目前磷酸化蛋白质研究的主要方法。在该策略中,蛋白质样品首先被酶解为肽段,进行富集后再进行液相-质谱串联分析。由于样品酶解液中磷酸肽的丰度极低,非磷酸肽干扰严重,而且磷酸肽的离子化效率不高,对质谱分析前的富集提出了很高的要求。(文献3,Lawrence R T,et al."Plug-and-playanalysis of the human phosphoproteome by targeted high-resolution massspectrometry".Nat.methods,2016,13,431-434;文献4,张传静等“基于MALDI-TOF MS的串联富集策略在磷酸化蛋白组学中的应用”分析测试学报,2017,36,1061-1068)As a very important protein post-translational modification, phosphorylation modification is involved in almost all life activities, such as cell proliferation, differentiation, apoptosis and neural activities. Abnormal phosphorylation usually leads to the occurrence of certain diseases, such as malignant tumors, senile dementia, etc. Therefore, it is of great significance to study the process and mechanism of protein phosphorylation modification for the prevention, control and treatment of diseases (Literature 1, Humphrey S.J., et.al "High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics" Nat. Biotechnol. 2015, 33, 990-995;
固定化金属离子亲和色谱(IMAC)是一种使用广泛的磷酸肽富集方法。该方法利用吸附剂上固定的金属离子,如Fe3+、Zr4+、Ti4+,可以与磷酸肽中的磷酸基团进行螯合作用,从而对酶解液中磷酸肽进行捕捉。(文献5,韩彬等“固定化金属离子亲和色谱研究进展”科技导报,2017,35,92-10)。传统的IMAC吸附剂在磷酸肽洗脱过程中,所使用的强碱性溶剂可能会破坏材料的组成,因此大多数吸附材料都是一次性的,不可重复使用。Immobilized metal ion affinity chromatography (IMAC) is a widely used method for enrichment of phosphopeptides. The method utilizes the immobilized metal ions on the adsorbent, such as Fe 3+ , Zr 4+ , Ti 4+ , which can chelate with the phosphate group in the phosphopeptide, thereby capturing the phosphopeptide in the enzymatic hydrolysis solution. (Document 5, Han Bin et al. "Research Progress on Immobilized Metal Ion Affinity Chromatography" Science and Technology Review, 2017, 35, 92-10). During the elution of phosphopeptides, traditional IMAC adsorbents may use strong alkaline solvents that may destroy the material composition, so most adsorbents are disposable and not reusable.
发明内容SUMMARY OF THE INVENTION
本发明涉及一种可重复使用的Zr4+-IMAC吸附材料。该材料以带有氨基官能团的纳米金刚石为基质,3,4,5-三羟基苯甲醛为修饰剂,采用氨醛缩合反应在金刚石表面引入联苯三酚基团,形成席夫碱,用硼氢化钠还原后,与锆离子进行螯合,即可得到用于富集磷酸肽的亲和色谱吸附材料。磷酸肽被吸附后,采用碱性洗脱液可以将其从吸附剂上洗脱下来,然后用酸性溶液平衡,该吸附剂可再次用来从样品溶液中富集磷酸肽。The present invention relates to a reusable Zr 4+ -IMAC adsorbent material. The material uses nano-diamonds with amino functional groups as the matrix and 3,4,5-trihydroxybenzaldehyde as the modifier. The amino-aldehyde condensation reaction is used to introduce the bipyloroglucinol group on the diamond surface to form a Schiff base. After sodium hydride is reduced, it is chelated with zirconium ions to obtain an affinity chromatography adsorption material for enriching phosphopeptides. After the phosphopeptide has been adsorbed, it can be eluted from the sorbent using a basic eluent and then equilibrated with an acidic solution, and the sorbent can be used again to enrich the phosphopeptide from the sample solution.
其结构示意式如下所示:Its structural schematic is as follows:
Zr4+-IMAC吸附材料具体制备过程包括如下步骤:The specific preparation process of Zr 4+ -IMAC adsorption material includes the following steps:
首先,在容器中将100~300mg纳米金刚石分散在10~20mL浓度为0.02~0.05g/mL的3,4,5-三羟基苯甲醛的乙醇溶液中,在60~80℃的条件下,以200~300rpm的速率磁力搅拌,加热回流4~12h,产物用乙醇洗涤;然后将产物分散在10~20mL浓度为0.005~0.02g/mL的硼氢化钠水溶液中,室温下以200~300rpm的速率磁力搅拌2~10h;反应结束后材料用水洗至中性,得到联苯三酚功能化的纳米金刚石颗粒;First, 100-300 mg of nano-diamonds were dispersed in 10-20 mL of ethanol solution of 3,4,5-trihydroxybenzaldehyde with a concentration of 0.02-0.05 g/mL in a container, under the condition of 60-80 ℃, with Magnetic stirring at a rate of 200-300 rpm, heating to reflux for 4-12 h, the product was washed with ethanol; then the product was dispersed in 10-20 mL of aqueous sodium borohydride solution with a concentration of 0.005-0.02 g/mL, at room temperature at a rate of 200-300 rpm Magnetic stirring for 2 to 10 hours; after the reaction, the material was washed with water until neutral to obtain bipyralol-functionalized nano-diamond particles;
将上述材料再一次分散在10~20mL浓度为0.5~1.0g/mL的氯化锆(ZrCl4)溶液中,室温下以100~150rpm的频率,振荡孵育反应4~8h,反应结束后用水洗涤至中性,50~80℃真空干燥6~12h,得到Zr4+-IMAC功能材料。Disperse the above materials once again in 10-20 mL of zirconium chloride (ZrCl 4 ) solution with a concentration of 0.5-1.0 g/mL, at room temperature at a frequency of 100-150 rpm, shake and incubate the reaction for 4-8 h, and wash with water after the reaction is complete to neutrality, and vacuum drying at 50-80°C for 6-12 hours to obtain Zr 4+ -IMAC functional material.
本发明的特征在于:The present invention is characterized in that:
(1)以带有氨基的纳米金刚石为基质,联苯三酚为配体,Zr4+为被螯合的金属离子制备Zr4+-IMAC功能材料;(1) Zr 4+ -IMAC functional material is prepared by using nanodiamond with amino group as matrix, pyrogallol as ligand, and Zr 4+ as chelated metal ion;
(2)该材料可用作固定化金属离子亲和色谱的吸附剂,高选择性地富集生物样品中的磷酸化肽段;(2) The material can be used as an adsorbent for immobilized metal ion affinity chromatography to enrich phosphorylated peptides in biological samples with high selectivity;
(3)该材料作为磷酸肽富集材料可以被重复使用。(3) The material can be reused as a phosphopeptide enrichment material.
传统的以磷酸根基团为配体的IMAC吸附剂,金属离子在碱性洗脱液中会随着磷酸肽从吸附剂上一同脱落,因而只能一次性使用。而本发明制备的IMAC吸附剂,由于配基与金属离子之间的强螯合作用力,在碱性洗脱液中金属离子不会从吸附剂表面解离。因此,磷酸肽洗脱后,材料用酸性溶液重新平衡后,可再次进行使用。In traditional IMAC adsorbents with phosphate groups as ligands, metal ions will fall off the adsorbent along with the phosphopeptides in the alkaline eluent, so they can only be used once. However, in the IMAC adsorbent prepared by the present invention, due to the strong chelating force between the ligand and the metal ion, the metal ion will not dissociate from the surface of the adsorbent in the alkaline eluent. Therefore, after elution of the phosphopeptide, the material can be used again after re-equilibration with an acidic solution.
本发明所述制备方法,反应条件温和,操作步骤简单,所得到的Zr4+-IMAC功能材料对磷酸肽的富集效果好,选择性强,可供重复使用,绿色环保,在样品前处理中展现出了良好的应用前景。The preparation method of the invention has mild reaction conditions, simple operation steps, and the obtained Zr 4+ -IMAC functional material has good enrichment effect on phosphopeptides, strong selectivity, can be reused, is green and environmentally friendly, and is processed before the sample. showed a good application prospect.
附图说明Description of drawings
图1.实施例中Zr4+-IMAC材料的(A)制备和(B)使用示意图。Figure 1. Schematic diagram of (A) preparation and (B) use of Zr 4+ -IMAC materials in the examples.
图2实施例中使用的纳米金刚石的透射电镜图。Figure 2 TEM image of the nanodiamonds used in the examples.
图3.实施例1中Zr4+-IMAC-1材料的X-衍射光电子能谱。(A)全谱图,(B)Zr 3d高分辨谱图。Figure 3. X-diffraction photoelectron spectrum of the Zr 4+ -IMAC-1 material in Example 1. (A) Full spectrum, (B) Zr 3d high-resolution spectrum.
图4.实施例1中β-酪蛋白酶解液的MALDI-TOF质谱分析图。(A)直接检测,(B)Zr4+-IMAC-1材料第一次富集后。(*)代表磷酸肽,(·)代表去磷酸碎片。Figure 4. MALDI-TOF mass spectrometry analysis of β-casein hydrolysate in Example 1. (A) Direct detection, (B) Zr 4+ -IMAC-1 material after first enrichment. (*) represents phosphopeptides, (·) represents dephosphorylated fragments.
图5.实施例1中,Zr4+-IMAC-1材料重复使用(A)在β-酪蛋白酶解液中富集到的三条特征磷酸肽的信号强度变化曲线图,(B)10次富集后的MALDI-TOF质谱分析图。(*)代表磷酸肽,(·)代表去磷酸碎片。Figure 5. In Example 1, the Zr 4+ -IMAC-1 material was repeatedly used (A) the signal intensity change curve of the three characteristic phosphopeptides enriched in the β-casein hydrolyzate, (B) 10 enrichment MALDI-TOF mass spectrometry after collection. (*) represents phosphopeptides, (·) represents dephosphorylated fragments.
图6.实施例1中β-酪蛋白与牛血清白蛋白混合酶解液(1/100,质量比)被Zr4+-IMAC-1材料(A)富集前,(B)富集后的MALDI-TOF质谱分析对比图。(*)代表磷酸肽,(·)代表去磷酸碎片。Figure 6. The mixed enzymatic hydrolysis solution of β-casein and bovine serum albumin (1/100, mass ratio) in Example 1 was enriched by Zr 4+ -IMAC-1 material (A) before and (B) after enrichment Comparison of MALDI-TOF mass spectrometry analysis. (*) represents phosphopeptides, (·) represents dephosphorylated fragments.
图7.实施例2中,(A)β-酪蛋白酶解液被Zr4+-IMAC-2材料首次富集后MALDI-TOF质谱分析图,(B)10次富集过程中,三条特征磷酸肽的信号强度变化曲线图。(*)代表磷酸肽,(·)代表去磷酸碎片。Figure 7. In Example 2, (A) MALDI-TOF mass spectrometry analysis of the β-casein hydrolyzate after the first enrichment by Zr 4+ -IMAC-2 material, (B) during the 10 enrichment process, three characteristic phosphate Graph of changes in signal intensity of peptides. (*) represents phosphopeptides, (·) represents dephosphorylated fragments.
图8.对比例中,β-酪蛋白酶解液被商品化的SPE-Ti-IMAC材料富集后的MALDI-TOF质谱分析图。(A)第一次富集。(B)第二次富集。(*)代表磷酸肽,(·)代表去磷酸碎片。Figure 8. In the comparative example, the MALDI-TOF mass spectrometry analysis of the β-casein hydrolyzate after enrichment with the commercial SPE-Ti-IMAC material. (A) First enrichment. (B) Second enrichment. (*) represents phosphopeptides, (·) represents dephosphorylated fragments.
具体实施方式Detailed ways
实施例1基于纳米金刚石制备的Zr4+-IMAC-1功能材料用于磷酸肽的分离富集Example 1 Zr 4+ -IMAC-1 functional materials prepared based on nanodiamonds are used for separation and enrichment of phosphopeptides
Zr4+-IMAC-1功能材料的制备:在圆底烧瓶中将100mg纳米金刚石(粒径范围:2~40nm)分散在10mL浓度为0.02g/mL的3,4,5-三羟基苯甲醛的乙醇溶液中,在70℃的油浴中,以250rpm的速率磁力搅拌,加热回流8h,产物用乙醇洗涤3次;然后分散在10mL浓度为0.01g/mL的硼氢化钠水溶液中,室温下以250rpm的速率磁力搅拌4h;反应结束后材料用水洗至中性,得到联苯三酚功能化的纳米金刚石颗粒;Preparation of Zr 4+ -IMAC-1 functional material: 100 mg of nanodiamonds (particle size range: 2-40 nm) were dispersed in 10 mL of 3,4,5-trihydroxybenzaldehyde with a concentration of 0.02 g/mL in a round-bottomed flask In the ethanol solution of the product, in an oil bath of 70 °C, magnetic stirring at a rate of 250 rpm, heating to reflux for 8 h, the product was washed with ethanol for 3 times; Magnetic stirring was carried out at a rate of 250 rpm for 4 h; after the reaction, the material was washed with water to neutrality to obtain bipyralol-functionalized nano-diamond particles;
将上述材料再一次分散在10mL浓度为0.5g/mL的氯化锆(ZrCL4)溶液中,室温下以150rpm的频率,孵育振荡反应8h,反应结束后用去离子水洗涤至中性,60℃真空干燥12h,得到Zr4+-IMAC功能材料。Disperse the above materials again in 10 mL of zirconium chloride (ZrCL 4 ) solution with a concentration of 0.5 g/mL, incubate and shake for 8 h at a frequency of 150 rpm at room temperature, and wash with deionized water after the reaction to neutrality, 60 Vacuum drying at ℃ for 12 h to obtain Zr 4+ -IMAC functional material.
酶解样品的制备:首先,将1mgβ-酪蛋白/牛血清白蛋白溶解在含8M尿素的100mM的碳酸氢铵水溶液中,调节pH到8.2。然后加入80μmol二硫苏糖醇,在60℃恒温水浴下加热1h。然后加入40μmol碘代乙酰胺,避光反应40min。接着用100mM的碳酸氢铵水溶液将尿素浓度稀释到1M后,按照蛋白质与胰蛋白酶的质量比为25:1的比例,加入胰蛋白酶。混合物在37℃水浴中孵育反应16h。最后将获得的酶解液用C18 SPE柱除盐,冷冻干燥后保存在-20℃的冰箱中备用。Preparation of enzymatic hydrolysis samples: First, 1 mg of β-casein/bovine serum albumin was dissolved in 100 mM ammonium bicarbonate aqueous solution containing 8 M urea, and the pH was adjusted to 8.2. Then, 80 μmol of dithiothreitol was added, and the mixture was heated in a constant temperature water bath at 60 °C for 1 h. Then, 40 μmol of iodoacetamide was added, and the reaction was performed in the dark for 40 min. Next, after diluting the urea concentration to 1 M with a 100 mM ammonium bicarbonate aqueous solution, trypsin was added at a ratio of protein to trypsin mass ratio of 25:1. The mixture was incubated in a 37°C water bath for 16h. Finally, the obtained enzymolysis solution was desalted with a C18 SPE column, freeze-dried and stored in a refrigerator at -20°C for future use.
磷酸肽的富集:首先,称取5mg Zr4+-IMAC-1材料于离心管中,用上样溶液(80%ACN,6%TFA)酸化平衡。然后将冻干后的蛋白酶解液用200μL上样溶液复溶,并转移至装有Zr4+-IMAC材料的离心管中。在室温下振荡30min后,以14,000rpm的转速离心,除去上清溶液。用洗涤溶液A(200mM NaCl,50%ACN,6%TFA)淋洗材料三次以除去非特异性吸附肽段,再用洗涤溶液B(30%ACN,0.1%TFA)淋洗三次除去材料中含有的盐,每次各振荡15min。最后用100μL质量百分比为8%的氨水溶液,将吸附到材料上的磷酸肽洗脱下来。洗脱液用MALDI-TOF MS分析。Enrichment of phosphopeptides: First, 5 mg of Zr 4+ -IMAC-1 material was weighed into a centrifuge tube and equilibrated with a loading solution (80% ACN, 6% TFA). The lyophilized proteolysis solution was then reconstituted with 200 μL of loading solution and transferred to a centrifuge tube containing Zr 4+ -IMAC material. After shaking at room temperature for 30 min, the supernatant solution was removed by centrifugation at 14,000 rpm. The material was rinsed three times with washing solution A (200 mM NaCl, 50% ACN, 6% TFA) to remove non-specifically adsorbed peptides, and then washed three times with washing solution B (30% ACN, 0.1% TFA) to remove the material contained in the material. Salt, shake for 15min each time. Finally, the phosphopeptide adsorbed on the material was eluted with 100 μL of 8% ammonia solution by mass. The eluate was analyzed by MALDI-TOF MS.
MALDI-TOF MS分析过程:首先,将0.5μL洗脱液滴加在MADLI靶上,自然晾干。然后再将0.5μL浓度为25mg/mL的2,5-二羟基苯甲酸溶液覆盖到样品点上,待完全晾干后,送入质谱仪进行分析。MALDI-TOF MS analysis process: First, drop 0.5 μL of the eluate on the MADLI target and let it dry naturally. Then, 0.5 μL of 2,5-dihydroxybenzoic acid solution with a concentration of 25 mg/mL was covered on the sample point, and after it was completely dried, it was sent to the mass spectrometer for analysis.
实施例2基于纳米金刚石制备的Zr4+-IMAC-2功能材料用于磷酸肽的分离富集Example 2 Zr 4+ -IMAC-2 functional materials prepared based on nanodiamonds are used for separation and enrichment of phosphopeptides
Zr4+-IMAC-2功能材料的制备:在圆底烧瓶中将100mg纳米金刚石(粒径范围:2~40nm)分散在3.3mL浓度为0.02g/mL的3,4,5-三羟基苯甲醛的乙醇溶液中,在70℃的油浴中,以250rpm的速率磁力搅拌,加热回流8h,产物用乙醇洗涤3次;然后分散在10mL浓度为0.01g/mL的硼氢化钠水溶液中,室温下以250rpm的速率磁力搅拌4h;反应结束后材料用水洗至中性,得到联苯三酚功能化的纳米金刚石颗粒;Preparation of Zr 4+ -IMAC-2 functional material: 100 mg of nanodiamonds (particle size range: 2-40 nm) were dispersed in 3.3 mL of 3,4,5-trihydroxybenzene with a concentration of 0.02 g/mL in a round-bottomed flask In an ethanol solution of formaldehyde, in an oil bath at 70 °C, magnetic stirring at a rate of 250 rpm, heating to reflux for 8 h, the product was washed three times with ethanol; magnetic stirring at a rate of 250 rpm for 4 h; after the reaction, the material was washed with water until neutral to obtain bipyralol-functionalized nano-diamond particles;
联苯三酚功能化的纳米金刚石颗粒的修饰与应用同实施例1The modification and application of bipyralol-functionalized nanodiamond particles are the same as in Example 1
对比例商业化IMAC微球用于磷酸化肽的分离富集Comparative Example Commercial IMAC Microspheres for Separation and Enrichment of Phosphorylated Peptides
商业化IMAC微球材料螯合钛:按照厂家说明书使用方法,取1.0g商品化IMAC微球(商品名:SPE-Ti-IMAC,购自百灵威科技有限公司),按1:100的比例与100g硫酸钛在水溶液中进行螯合12h,依次用10mL 0.1%TFA、200mM NaCl水溶液和去离子水洗净微球上未被螯合的钛离子,50℃真空干燥6h,得到商品化Ti-IMAC材料。Commercially available IMAC microsphere material chelated titanium: according to the manufacturer's instructions, take 1.0g of commercial IMAC microspheres (trade name: SPE-Ti-IMAC, purchased from Bailingwei Technology Co., Ltd.), and add 100g of it at a ratio of 1:100. Titanium sulfate was chelated in an aqueous solution for 12 h, followed by washing the unchelated titanium ions on the microspheres with 10 mL of 0.1% TFA, 200 mM NaCl aqueous solution and deionized water, and vacuum drying at 50 °C for 6 h to obtain a commercial Ti-IMAC material .
商业化Ti-IMAC材料富集磷酸化肽:磷酸肽富集与质谱分析过程同实施例1。Commercial Ti-IMAC material enriches phosphorylated peptides: The process of phosphorylated peptide enrichment and mass spectrometry analysis is the same as that in Example 1.
材料合成与表征:Material Synthesis and Characterization:
图1为实施例中Zr4+-IMAC材料的制备示意图。纳米金刚石表面带有大量的氨基集团,可以与单体3,4,5-三羟基苯甲醛中的醛基发生氨醛缩合反应,将单体中的联苯三酚基团引入纳米颗粒表面,该基团可作为配体与锆离子发生螯合作用,将锆离子螯合在纳米颗粒表面。利用锆离子与磷酸肽中的磷酸根的螯合作用,该纳米颗粒可作为IMAC的吸附剂富集样品溶液中的磷酸肽。Figure 1 is a schematic diagram of the preparation of Zr 4+ -IMAC materials in the examples. The surface of the nano-diamond has a large number of amino groups, which can undergo amino-aldehyde condensation reaction with the aldehyde group in the
图2为实施例中所使用的纳米金刚石的透射电镜图。该材料为无定型颗粒,大部分颗粒尺寸在20nm以下。FIG. 2 is a transmission electron microscope image of the nanodiamond used in the examples. The material is amorphous particles, most of which are below 20 nm in size.
图3A为实施例1中Zr4+-IMAC-1材料的X-衍射光电子能谱的全谱图,图3B为Zr 3d高分辨谱图。谱图表明该材料中含有C、O、N及Zr元素,印证了合成路线。锆离子成功螯合在了Zr4+-IMAC材料的表面。3A is a full spectrum of the X-diffraction photoelectron spectrum of the Zr 4+ -IMAC-1 material in Example 1, and FIG. 3B is a high-resolution spectrum of Zr 3d. The spectrum shows that the material contains C, O, N and Zr elements, which confirms the synthetic route. Zirconium ions were successfully chelated on the surface of Zr 4+ -IMAC material.
材料应用Material application
由于Zr 4+离子与联苯三酚之间的螯合作用力大于其与磷酸基团之间的螯合力,因此在富集完成之后,通过碱性洗脱剂,可以仅将磷酸肽从吸附剂上洗脱,而不使Zr4+从吸附剂上解离,所以磷酸肽洗脱完成后,用酸性溶液重新平衡,吸附材料可再次进行使用。Since the chelation force between the Zr 4+ ion and the pyrogallol is greater than the chelation force between it and the phosphate group, after the enrichment is completed, only the phosphopeptide can be removed from the adsorbent by the alkaline eluent. Elution without dissociating Zr 4+ from the adsorbent, so after the elution of the phosphopeptide is completed, it is re-equilibrated with an acidic solution, and the adsorbent material can be used again.
图4为实施例1中β-酪蛋白酶解液第一次富集前后的对比图。富集前(图4A),三条特征磷酸肽(2061、2556、3122,m/z)由于丰度低,信号干扰严重,很难被检测。而用Zr4+-IMAC-1富集后,非糖肽信号峰基本消失,三条特征磷酸肽及它们的去磷酸碎片峰(1963、2458、3024、2926,m/z)占据了谱图的主要位置。这说明材料对磷酸肽有很好的富集能力。FIG. 4 is a comparison diagram before and after the first enrichment of the β-casein hydrolyzate in Example 1. FIG. Before enrichment (Fig. 4A), the three characteristic phosphopeptides (2061, 2556, 3122, m/z) were difficult to detect due to their low abundance and severe signal interference. However, after enrichment with Zr 4+ -IMAC-1, the non-glycopeptide signal peaks basically disappeared, and three characteristic phosphopeptides and their dephosphorylated fragment peaks (1963, 2458, 3024, 2926, m/z) occupied the upper part of the spectrum. main location. This indicates that the material has a good enrichment ability for phosphopeptides.
实施例1中,为了考察Zr4+-IMAC-1材料的重复使用性能,一个10轮的循环富集实验被执行。将10mg的Zr4+-IMAC材料作为循环使用的吸附剂,每次都富集10μg的β-酪蛋白酶解液。每次富集过程完成后,用8%的氨水溶液将吸附在材料上的磷酸肽洗脱下来进行质谱检测,吸附剂再用酸性上样溶液进行酸化平衡,进入下一轮的磷酸肽富集实验,如此进行10次循环实验。结果如图5所示。图5A表明Zr4+-IMAC-1材料被重复使用十次后,从β-酪蛋白酶解液中富集到的三条特征磷酸肽的信号强度都没有明显的下降趋势,表明该材料作为IMAC吸附剂具有良好的可重复使用性。In Example 1, in order to investigate the reusability of the Zr 4+ -IMAC-1 material, a 10-round cyclic enrichment experiment was performed. 10 mg of Zr 4+ -IMAC material was used as the adsorbent for recycling, and 10 μg of β-casein hydrolysate was enriched each time. After each enrichment process is completed, the phosphopeptide adsorbed on the material is eluted with 8% aqueous ammonia solution for mass spectrometry detection, and the adsorbent is then acidified and equilibrated with an acidic loading solution to enter the next round of phosphopeptide enrichment. Experiment, 10 cycles of experiments were performed in this way. The results are shown in Figure 5. Figure 5A shows that after the Zr 4+ -IMAC-1 material was reused ten times, the signal intensities of the three characteristic phosphopeptides enriched from the β-casein hydrolyzate had no obvious downward trend, indicating that the material was adsorbed as IMAC The agent has good reusability.
实施例1中,为了考察Zr4+-IMAC-1材料的特异性,我们将质量比为1/100的β-酪蛋白/牛血清白蛋白混合酶解液作为样品,进行了磷酸肽富集。富集前(图6A),检测到肽段几乎都是非磷酸肽,而富集后(图6B)没有明显的非磷酸肽的信号出现,谱图中明显的信号峰都归属于磷酸肽及其去磷酸碎片。这说明Zr4+-IMAC-1材料对磷酸肽具有很高的特异性。In Example 1, in order to investigate the specificity of the Zr 4+ -IMAC-1 material, we used the β-casein/bovine serum albumin mixed enzymatic hydrolyzate with a mass ratio of 1/100 as a sample, and carried out phosphopeptide enrichment. . Before enrichment (Fig. 6A), the detected peptides were almost all non-phosphopeptides, but after enrichment (Fig. 6B), no obvious signal of non-phosphopeptide appeared, and the obvious signal peaks in the spectrum were all attributed to phosphopeptides and their phosphopeptides. Dephosphorylation fragments. This indicates that the Zr 4+ -IMAC-1 material has high specificity for phosphopeptides.
为了考察配体3,4,5-三羟基苯甲醛对于Zr4+-IMAC功能材料富集性能的影响,在实施例2的材料制备过程中将配体的加入量变为实施例1的三分之一左右,其余条件与实施例1相同。得到的Zr4+-IMAC-2功能材料同样以β-酪蛋白酶解液为样品,进行了10轮的循环富集实验,结果如图7所示。图7A显示,首轮富集后,质谱图中非磷酸肽信号值也基本消失,图中明显的信号峰均为磷酸肽信号峰及其去磷酸化碎片信号峰,说明Zr4+-IMAC-2材料对磷酸肽具有很高的选择性。但是相比于实施例1制备的Zr4+-IMAC-1而言,磷酸肽的信号峰强度普遍下降,这可能是因为在材料的制备过程中配体3,4,5-三羟基苯甲醛的使用量减少,导致可供Zr4+螯合的位点也相应减少,因此材料的富集能力下降。但是与实施例1相似,富集10轮后,三条特征磷酸肽的峰强度并没有明显的下降趋势(图7B),表明Zr4+-IMAC-2材料具有优异的可重复使用性。In order to investigate the effect of the
为了与Zr4+-IMAC材料的富集性能进行对比,在对比例中,商品化的SPE-Ti-IMAC也被用来作为IMAC吸附剂,富集磷酸肽。图8A显示,虽然SPE-Ti-IMAC也可以从β-酪蛋白酶解液中富集到三条特征的磷酸肽,但是,非磷酸肽的信号峰依然不能完全忽略。磷酸肽从材料上洗脱后,即使用酸性溶液洗涤平衡,材料也失去了富集磷酸肽的能力,洗脱液中检测不到磷酸肽的信号(图8B),该材料不可以被重新使用。其原因可能是在磷酸肽的洗脱过程中,碱性氨水洗脱液不仅可以破坏磷酸肽中磷酸基团与Ti4+的螯合作用,同时也破坏了Ti4+与吸附剂上磷酸配体之间的螯合作用,从而使磷酸肽从吸附剂上解离的同时,固定在吸附剂表面的Ti4+也从吸附剂上解离。以上结果表明以纳米金刚石为基质,联苯三酚为配体,锆离子(IV)为螯合金属离子所制备的Zr4+-IMAC材料比商品化的SPE-Ti-IMAC对复杂样品中的磷酸肽具有更高的富集效率及特异性,而且该材料可以被重复使用,而商品化材料仅能一次性使用。In order to compare with the enrichment performance of Zr 4+ -IMAC material, in the comparative example, commercial SPE-Ti-IMAC was also used as IMAC adsorbent to enrich phosphopeptides. Figure 8A shows that although SPE-Ti-IMAC can also enrich three characteristic phosphopeptides from β-casein hydrolysate, the signal peaks of non-phosphopeptides cannot be completely ignored. After the phosphopeptide was eluted from the material, even if it was washed and equilibrated with an acidic solution, the material lost the ability to enrich the phosphopeptide, and the signal of the phosphopeptide could not be detected in the eluate (Fig. 8B), and the material could not be reused . The reason may be that during the elution of phosphopeptides, the alkaline ammonia eluent can not only destroy the chelation of phosphate groups in phosphopeptides and Ti 4+ , but also destroy the complexation between Ti 4+ and phosphoric acid on the adsorbent. At the same time, the chelation between the phosphopeptides and the adsorbent dissociates from the adsorbent, and the Ti 4+ immobilized on the surface of the adsorbent is also dissociated from the adsorbent. The above results show that the Zr 4+ -IMAC material prepared with nanodiamond as the matrix, bipyralol as the ligand, and zirconium (IV) as the chelated metal ion is more effective than the commercial SPE-Ti-IMAC in the complex sample. Phosphopeptides have higher enrichment efficiency and specificity, and the material can be reused, while commercial materials can only be used once.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110249329.1A CN115041138B (en) | 2021-03-08 | 2021-03-08 | A phosphorylated peptide adsorbent based on nanodiamond and its preparation and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110249329.1A CN115041138B (en) | 2021-03-08 | 2021-03-08 | A phosphorylated peptide adsorbent based on nanodiamond and its preparation and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115041138A true CN115041138A (en) | 2022-09-13 |
| CN115041138B CN115041138B (en) | 2023-09-26 |
Family
ID=83156843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110249329.1A Expired - Fee Related CN115041138B (en) | 2021-03-08 | 2021-03-08 | A phosphorylated peptide adsorbent based on nanodiamond and its preparation and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115041138B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396650A (en) * | 2007-09-26 | 2009-04-01 | 中国科学院大连化学物理研究所 | Titanium ion fixation affinity chromatography material and preparation and use thereof |
| CN102395886A (en) * | 2009-04-17 | 2012-03-28 | 玛丽女王和威斯菲尔德学院 | Method for quantifying modified peptides |
| US20130112605A1 (en) * | 2010-07-26 | 2013-05-09 | Waters Technologies Corporation | Superficially porous materials comprising a substantially nonporous core having narrow particle size distribution; process for the preparation thereof; and use thereof for chromatographic separations |
| CN111939876A (en) * | 2020-07-24 | 2020-11-17 | 华南理工大学 | MOF @ activated carbon cellulose special paper and preparation method and application thereof |
-
2021
- 2021-03-08 CN CN202110249329.1A patent/CN115041138B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396650A (en) * | 2007-09-26 | 2009-04-01 | 中国科学院大连化学物理研究所 | Titanium ion fixation affinity chromatography material and preparation and use thereof |
| CN102395886A (en) * | 2009-04-17 | 2012-03-28 | 玛丽女王和威斯菲尔德学院 | Method for quantifying modified peptides |
| US20130112605A1 (en) * | 2010-07-26 | 2013-05-09 | Waters Technologies Corporation | Superficially porous materials comprising a substantially nonporous core having narrow particle size distribution; process for the preparation thereof; and use thereof for chromatographic separations |
| CN111939876A (en) * | 2020-07-24 | 2020-11-17 | 华南理工大学 | MOF @ activated carbon cellulose special paper and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115041138B (en) | 2023-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Highly selective and rapid enrichment of phosphorylated peptides using gallium oxide‐coated magnetic microspheres for MALDI‐TOF‐MS and nano‐LC‐ESI‐MS/MS/MS analysis | |
| Jiang et al. | Facile synthesis of Fe3O4@ PDA core-shell microspheres functionalized with various metal ions: A systematic comparison of commonly-used metal ions for IMAC enrichment | |
| CN103894161B (en) | A kind of synthetic method of magnetic metal organic framework composite material and application thereof | |
| Dunn et al. | Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry | |
| Sun et al. | Hydrophilic Nb5+-immobilized magnetic core–shell microsphere–A novel immobilized metal ion affinity chromatography material for highly selective enrichment of phosphopeptides | |
| CN113351190B (en) | A kind of immobilized metal ion affinity chromatography microsphere material and its preparation and application | |
| CN103143331A (en) | Synthesis and application of [Cu3(btc)2] metal-organic framework composites coated on the surface of magnetic microspheres ferric oxide | |
| CN114011376B (en) | Metal oxidation affinity chromatography magnetic mesoporous nano material, preparation method and application | |
| CN113318715B (en) | Phosphorylated peptide adsorbent and preparation and application thereof | |
| Zhang et al. | Facile synthesis of gallium ions immobilized and adenosine functionalized magnetic nanoparticles with high selectivity for multi-phosphopeptides | |
| CN106770614B (en) | Identification of Glycosylated Peptides Using Hydrophilic Nanocomposites Combined with Mass Spectrometry | |
| CN110575825B (en) | A kind of phosphoric acid functionalized and Ti-IMAC carbon material and its preparation and application | |
| Zhang et al. | Phytic acid functionalized Fe3O4 nanoparticles loaded with Ti (IV) ions for phosphopeptide enrichment in mass spectrometric analysis | |
| CN101054406A (en) | Method of separating and enriching phosphated peptide section by metal oxide magnetic micro-sphere | |
| CN106432644B (en) | A kind of hydrophilic polymers functional magnetic nanoparticle and its preparation method and application | |
| CN105203380A (en) | Preparation method and application of magnetic MIL-100 composite material | |
| CN105363426A (en) | Peptide identification method by using mesoporous silica composite combined with mass spectrum | |
| Long et al. | Low-cost iron oxide magnetic nanoclusters affinity probe for the enrichment of endogenous phosphopeptides in human saliva | |
| CN105536748A (en) | Method for identification of phosphopeptide through combination of nanometer composite material and mass spectrometry | |
| Wang et al. | Pyridoxal 5′-phosphate mediated preparation of immobilized metal affinity material for highly selective and sensitive enrichment of phosphopeptides | |
| CN101747448B (en) | Nano chitosan derivative and preparation method and application thereof | |
| CN102760543B (en) | Hydrophilic metal ion immobilization affinity magnetic bead and preparation and application thereof | |
| He et al. | Removal of adsorption sites on the external surface of mesoporous adsorbent for eliminating the interference of proteins in enrichment of phosphopeptides/nucleotides | |
| Hu et al. | An efficient strategy with a synergistic effect of hydrophilic and electrostatic interactions for simultaneous enrichment of N-and O-glycopeptides | |
| Zhang et al. | Development of dual-ligand titanium (IV) hydrophilic network sorbent for highly selective enrichment of phosphopeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20230926 |